Based on the forecasted data, the use of respiratory system medicines in Denmark is set to increase steadily over the next five years as follows: 2024: 175.5, 2025: 180.2, 2026: 185.0, 2027: 189.7, and 2028: 194.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. The year-on-year percentage variations are 2.68% (2024-2025), 2.67% (2025-2026), 2.54% (2026-2027), and 2.42% (2027-2028). The compound annual growth rate (CAGR) over the five years is approximately 2.58%.
Future trends to watch include the potential impact of new respiratory therapies and medications, changes in healthcare policies, and shifts in population demographics that might affect medicine usage rates. Advances in preventive care and treatment options could also influence the forecasted trends.
